Status:

COMPLETED

Impact of Preterm Body Composition at Discharge on 2 Years Neurological Development (ASQ Evaluation)

Lead Sponsor:

Nantes University Hospital

Conditions:

Other Preterm Infants

Eligibility:

All Genders

25-35 years

Brief Summary

Neonatal nutritional management consists in reproducing miming uteri growth kinetic. Since the seventies, NICU (Neonatal Intensive Care Unit) strategy consists in a high proteidic input (apport) suppo...

Eligibility Criteria

Inclusion

  • Preterm newborns (\< 35 weeks gestation).
  • Final clinical discharge (No transfer)
  • Oral Parental consent.
  • Nantes NICU Neonatal management in the first 5 days of life

Exclusion

  • Congenital pathology inconsistent with PEAPOD investigation (Beckwith-Wiedemann syndrome, lipodystrophia with abnormal constitutional fat mass level).
  • Pathology inducing neurodevelopment troubles.
  • Transfer in an other hospital before discharge
  • Hemodynamic or cardiovascular instability requiring continuous monitoring or perfusion, incompatible with PEAPOD measurement

Key Trial Info

Start Date :

September 1 2011

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

October 1 2014

Estimated Enrollment :

270 Patients enrolled

Trial Details

Trial ID

NCT01450436

Start Date

September 1 2011

End Date

October 1 2014

Last Update

February 21 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Nantes University Hospital

Nantes, France, 44093